Grip strength and cardiovascular drug use in older people: Findings from the Hertfordshire Cohort Study

Age and Ageing

Volumn 39, Issue 2, 2009, Pages 185-191

  Ashfield, T A ^a   Syddall, H E ^b   Martin, H J ^b   Dennison, E M ^b   Cooper, C ^b   Aihie Sayer, A ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Ageing; Cardiovascular drugs; Elderly; Grip strength; Sarcopenia

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; FUNCTIONAL STATUS; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT;

ACTIVITIES OF DAILY LIVING; AGED; AGING; CARDIOVASCULAR AGENTS; COHORT STUDIES; ENGLAND; FEMALE; GERIATRIC ASSESSMENT; HAND STRENGTH; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; QUESTIONNAIRES; SEX FACTORS;

EID: 77949361481     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afp203     Document Type: Article

References (34)

1. Roubenoff R. Sarcopenia: a major modifiable cause of frailty in the elderly. J Nutr Health Aging 2000; 4140-2.
2. Sayer AA, Syddall HE, Dennison EM et al. Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM 2007; 100: 707-13.
3. Bohannon RW. Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther. 2008; 313-10.
4. Sirola J, Rikkonen T, Tuppurainen M et al. Association of grip strength change with menopausal bone loss and related fractures: a population based follow-up study. Calcif Tissue Int 2006; 78: 218-26.
5. Kerr A, Syddall HE, Cooper C et al. Does admission grip strength predict length of stay in hospitalised older patients? Age Ageing 2006; 35: 82-4.
6. Rumble RH, Morgan K. Longitudinal trends in prescribing for elderly patients: two surveys four years apart. Br J Gen Pract 1994; 44: 571-5.
7. Gorard DA. Escalating polypharmacy. QJM 2006; 99: 797-800.
8. Stuck AE, Beers MH, Steiner A et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 1542195-200.
9. McGavock H. The Scientific Basis of Prescribing in the Elderly. Prescriber 2002; 1386-9http://www.escriber.com/Prescriber/Features.asp?ID=384&GroupID=37&Action=View (accessed 13 Nov 2007).
10. Tanner LA, Baum C. Spontaneous adverse reaction reporting in the elderly. Lancet 1988; 2: 580.
11. Department of Health. National Service Framework for Older People. London: Department of Health, 2001.
12. Office of National Statistics. Prescriptions Dispensed in the Community Statistics for 1996 to 2006: England. 2007; URL: http://www.ic.nhs.uk/webfiles/publications/PrescDispensed %2096to06/Bulletin%20220807%20version%20for%202006. pdf (accessed 8 Dec 2008).
13. Lawlor DA, Patel R, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327: 712-7.
14. Pasternak RC, Smith SC Jr., Bairey-Merz CN et al. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Stroke 2002; 332337-41.
15. Scott D, Blizzard L, Fell J et al. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM 2009; 102: 625-33.
16. Onder G, Penninx BW, Balkrishnan R et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 2002; 359: 926-30.
17. Carter CS, Onder G, Kritchevsky SB et al. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J Gerontol A Biol Sci Med Sci 2005; 60; 1437-46.
18. Syddall HE, Aihie SA, Dennison EM et al. Cohort profile: the Hertfordshire Cohort Study. Int J Epidemiol 2005; 34; 1234-42.
19. Ensrud KE, Nevitt MC, Yunis C et al. Correlates of impaired function in older women. J Am Geriatr Soc 1994; 42; 481-9.
20. Sayer AA, Dennison EM, Syddall HE et al. Type 2 diabetes, muscle strength and impaired physical function: the tip of the iceberg? Diabetes Care 2005; 28: 2541-2.
21. Sayer AA, Syddall HE, Martin HJ et al. Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing 2006; 35: 409-15.
22. van Mil HG, Geukes Foppen RJ, Siegenbeek vH. The influence of bumetanide on the membrane potential of mouse skeletal muscle cells in isotonic and hypertonic media. Br J Pharmacol 1997; 120: 39-44.
23. Tsau YK, Tsai WY, Lu FL et al. Symptomatic hypomagnesemia in children. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chih 1998; 39: 393-7.
24. Shintani S, Shiigai T, Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur Neurol 1991; 31: 396-8.
25. Joint Formulary Committee. British National Formulary. 55th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2008.
26. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001; 81: 209-37.
27. Forrest KY, Zmuda JM, Cauley JA. Patterns and determinants of muscle strength change with aging in older men. Aging Male 2005; 8: 151-6.
28. Ozkul Y. Influence of calcium channel blocker drugs in neuromuscular transmission. Clin Neurophysiol 2007; 118: 2005-8.
29. Matzno S, Yasuda S, Kitada Y et al. Clofibrate-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation. Life Sci 2006; 78: 1892-9.
30. Agostini JV, Tinetti ME, Han L et al. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc 2007; 55: 420-5.
31. Traustadóttir T, Stock AA, Harman SM. High-dose statin use does not impair aerobic capacity or skeletal muscle function in older adults. Age (Dordr). 2008; 30: 283-91.
32. Grundy SM. Can statins cause chronic low-grade myopathy. Ann Intern Med 2002; 137: 617-8.
33. Sumukadas D, Witham MD, Struthers AD et al. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ 2007; 9177867-74.
34. Syddall HE, Simmonds SJ, Martin HJ et al for the Hertfordshire Cohort Study Group. Cohort profile: the Hertfordshire Ageing Study (HAS). Int J Epidemiol 2009 Jan 8. [Epub ahead of print].